Securities Class Action Filed Against Alto Neuroscience, Inc.

Strategic Insights -

Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Alto Neuroscience, Inc. ("Alto" or the "Company") and reminds investors of the September 19, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. The complaint alleges that Alto and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that Alto-100, the Company's treatment for Major Depressive Disorder (MDD), was less effective than Defendants had led investors to believe.

Key Takeaways:

  • The lawsuit alleges that Alto made false and/or misleading statements and/or failed to disclose that Alto-100 was not effective in treating MDD.
  • The Company's executives are accused of violating federal securities laws, which led to the Company's stock price falling by 69.99% after the announcement of topline results from the Phase 2b trial evaluating Alto-100.
  • Analysts were quick to comment on the Company's announcement, with Jeffries cutting its price target for Alto to $17 from $33.
  • Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
  • The law firm responsible for this advertisement is Faruqi & Faruqi, LLP.

Statistics:

  • $10.17: the amount by which Alto's stock price fell per share after the announcement of topline results from the Phase 2b trial evaluating Alto-100.
  • 69.99%: the percentage by which Alto's stock price fell after the announcement.
  • 4.36: the closing price of Alto's stock on October 23, 2024.
  • 877-247-4292 and 212-983-9330 (Ext. 1310): the telephone numbers to contact Faruqi & Faruqi partner Josh Wilson directly.
  • 1995: the year in which Faruqi & Faruqi was founded.
  • 22,000+ years: the number of years that Faruqi & Faruqi has been recovering millions of dollars for investors.

Sources:

  • Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson
  • NYSE: ANRO
  • Newsfile Corp.
  • www.faruqilaw.com
  • www.newsfilecorp.com